Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders
1. Johnson Fistel investigates DexCom for potential fiduciary breaches. 2. DexCom issued misleading statements about its market strategy since April 2023. 3. Shares dropped over 40.6% following corrective disclosures in mid-2024. 4. Current stockholders are advised to discuss legal rights. 5. Investigation follows public disclosures of lower-than-expected growth.